Synaptic plasticity is the brain's capacity to change the strength of its connections based on use. Synapses that fire together strengthen; synapses that fail to coordinate weaken. This is the cellular basis of all learning, all memory, all therapeutic change in psychotherapy, and most of the slow effects of psychiatric medication.
The two foundational mechanisms are long-term potentiation (LTP) and long-term depression (LTD). LTP strengthens a synapse. LTD weakens it. Together they allow circuits to learn associations, forget irrelevant ones, and reorganize in response to experience.
LTP requires the NMDA glutamate receptor, which we met as a coincidence detector. NMDA opens only when glutamate is present and the postsynaptic membrane is depolarized. When both conditions are met, calcium flows into the dendrite. The calcium signal triggers a cascade that inserts more AMPA receptors into the postsynaptic membrane, strengthening that synapse for hours, days, or longer. The synapse is now more sensitive to future presynaptic firing.
LTD involves lower-intensity activation. When the calcium signal is smaller and more sustained (rather than brief and intense), the cascade triggers AMPA receptor removal from the postsynaptic membrane. The synapse weakens. This is how circuits prune connections that are not earning their place.
These mechanisms operate continuously throughout life. When you learn something — a face, a fact, a skill — networks of synapses are strengthening through LTP and weakening through LTD until the pattern stabilizes. The hippocampus uses LTP heavily during encoding. The cortex uses LTP and LTD during consolidation. Procedural learning in the basal ganglia and cerebellum involves the same mechanisms in different anatomy.
Clinically, synaptic plasticity is one of the candidate mechanisms for the rapid antidepressant effect of ketamine. Ketamine blocks NMDA receptors, which should impair LTP — but the actual effect appears more complex. The leading hypothesis is that ketamine triggers a burst of downstream glutamate release, activates AMPA receptors, and resets synaptic strength in mood-regulating circuits, producing rapid plasticity changes that lift depression within hours.
Psychotherapy works through synaptic plasticity too. When a patient repeatedly activates a trauma memory in a safe context during prolonged exposure therapy, the synapses encoding the threat association weaken (LTD) while synapses encoding the safety association strengthen (LTP). The therapy is not changing the patient's mind in a metaphorical sense; it is changing the brain through cellular plasticity that has been understood for decades.
BDNF (brain-derived neurotrophic factor) is a key molecule that supports plasticity. SSRIs, ketamine, exercise, and many other interventions raise BDNF levels in mood-regulating circuits. The plasticity-enabling effect of BDNF is part of why these interventions produce lasting therapeutic effects rather than just temporary symptomatic relief.
Hold the principle. The brain is plastic. Synapses strengthen and weaken based on use. Learning, memory, therapy, and medication all converge on this fundamental property. The brain you are working with today is not the brain it will be after a course of effective treatment — and not just metaphorically.